Moderna plans to begin its final phase of testing for the COVID-19 vaccine on July 27
Change language:
An investigational COVID-19 vaccine, mRNA-1273, was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online Tuesday in The New England Journal of Medicine.
The ongoing phase 1 trial is supported by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
The experimental vaccine, co-developed by researchers at NIAID and U.S. biotech company Moderna, is designed to induce neutralizing antibodies directed at a portion of the coronavirus “spike” protein, which the virus uses to bind to and enter human cells.
The trial, led by Lisa Jackson of Kaiser Permanente Washington Health Research Institute in Seattle, was launched on March 16 when the first participant received the candidate vaccine.
The interim report detailed the initial findings from the first 45 participants aged 18-55 enrolled at the study sites in Seattle and at Emory University in Atlanta.
Three groups of 15 participants received two intramuscular injections, 28 days apart, of either 25, 100 or 250 micrograms of the investigational vaccine.
If anyone takes this vaccine they are taking the Biblical Mark of the Beast from the Book of Revelations in The Holy Bible. This vaccine will not only alter your DNA it will set you apart from The Creator and make you trackable with the Nano tracking devices contained with in it with 5G technology. You will no longer be able to enter The Kingdom of Heaven. You will spend eternity in Hell. DO NOT allow ANYONE to inject you with this vaccine. Better to die from CV19 than spend eternity in the lake of fire.